Atea Pharmaceuticals Inc
AVIR - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$329.64M
Close$
$1.16
71.6% downside
Current Fair Value
71.6% downsideOvervalued by 71.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $329.64 Million |
|---|---|
| Enterprise Value | $253.52 Million |
| Earnings per Share | $-1.94 |
| Beta | 0.29 |
| Outstanding Shares | 80,050,518 |
Return
| Return on Equity | -80.96% |
|---|---|
| Return on Assets | -71.16% |
| Return on Invested Capital | -88.86% |
Valuation & Multiples
| P/E Ratio | -1.98 |
|---|---|
| PEG | 17.37 |
| Price to Sales | - |
| Price to Book Ratio | 2.05 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.4 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.56
Consensus analyst estimateRevenue Estimate
$33.03 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.55
Consensus analyst estimateRevenue Estimate
$50.45 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.01%▼ 74.87% |
|---|---|
| Total Invested | $4.20M▼ 98.50% |
| Investors Holding | 25▼ 102.00% |
About Atea Pharmaceuticals Inc
39 employees
Atea is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing therapies to address the unmet medical needs of patients with life-threatening viral diseases. Leveraging its deep understanding of...